Modeling the cost of management options for stage I nonseminomatous germ cell tumors: A decision tree analysis

Journal of Clinical Oncology

Volumn 23, Issue 24, 2005, Pages 5762-5773

  Link, Richard E ^a   Allaf, Mohamad E ^a   Pili, Roberto ^a   Kavoussi, Louis R ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH PROGRAM; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MALE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; META ANALYSIS; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; SURGICAL APPROACH; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; DECISION TREE; ECONOMICS; GERM CELL TUMOR; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PATHOLOGY; TESTIS TUMOR;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; DECISION TREES; GERMINOMA; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; TESTICULAR NEOPLASMS;

EID: 24944501733     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.09.308     Document Type: Article

References (18)

1. Baniel J, Roth BJ, Foster RS, et al: Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors. Ann Surg Oncol 3:86-93, 1996
2. Lashley DB, Lowe BA: A rational approach to managing stage I nonseminomatous germ cell cancer. Urol Clin North Am 25:405-423, 1998
3. Clinical Practice Guidelines in Oncology: Testicular Cancer. Version 1. 2004. http://www.nccn.org/professionals/physician_gls/PDF/testicular.pdf
4. Consumer Price Index Calculator: Inflation Calculator. http://data.bls.gov/cgi-bin/cpicalc.pl
5. Porter J, Obek C, Lange PH: The management of stage I nonseminomatous germ cell tumor. Campbells Urol Updates 2:1-12, 2004
6. Baniel J, Foster RS, Rowland RG, et al: Complications of primary retroperitoneal lymph node dissection. J Urol 152:424-427, 1994
7. Heidenreich A, Albers P, Hartmann M, et al: Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: Experience of the German Testicular Cancer Study Group. J Urol 169:1710-1714, 2003
8. Donohue JP, Thornhill JA, Foster RS, et al: The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: The Indiana University experience (1965 to 1989). J Urol 153:85-89, 1995
9. Donohue JP, Foster RS, Rowland RG, et al: Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 144:287-292, 1990
10. Jewett MA, Kong YS, Goldberg SD, et al: Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 139:1220-1224, 1988
11. Bohlen D, Borner M, Sonntag RW, et al: Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular non-seminomatous malignant germ cell tumors with high risk factors. J Urol 161:1148-1152, 1999
12. Studer UE, Burkhard FC, Sonntag RW: Risk adapted management with adjuvant chemotherapy in patients with high risk clinical stage I nonseminomatous germ cell tumor. J Urol 163: 1785-1787, 2000
13. Cullen MH, Stenning SP, Parkinson MC, et al: Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A Medical Research Council report. J Clin Oncol 14:1106-1113, 1996
14. Pont J, Albrecht W, Postner G, et al: Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: Long-term results of a prospective trial. J Clin Oncol 14:441-448, 1996
15. Oliver RT, Raja MA, Ong J, et al: Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage 1 malignant teratoma on overall relapse rate of stage 1 cancer patients. J Urol 148:1453-1456, 1992
16. Ogan K, Lotan Y, Koeneman K, et al: Laparoscopic versus open retroperitoneal lymph node dissection: A cost analysis. J Urol 168: 1945-1949, 2002
17. Read G, Stenning SP, Cullen MH, et al: Medical Research Council prospective study of surveillance for stage I testicular teratoma: Medical Research Council Testicular Tumors Working Party. J Clin Oncol 10:1762-1768, 1992
18. Boshoff C, Begent RH, Oliver RT, et al: Secondary tumours following etoposide containing therapy for germ cell cancer. Ann Oncol 6:35-40, 1995